Japan’s Eneos to Acquire TPC; FDA Approves Twice-Rejected Melanoma Drug
Japan’s Eneos plans to acquire TPC and the FDA approved a melanoma drug, while major chemical makers like BASF reported soaring Q2 profits driven by Middle East supply disruptions.
cen · 2026-08-11 00:00